Physician profile
Pooja Gupta
NPI 1205044062
$4,061.19
in general payments reported to CMS, 2019-2025
25 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $151 · 2021: $1,396 · 2022: $1,532 · 2023: $126 · 2024: $67.43 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,480.57 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $279.56 | 2019-2022 | |
| Glaxosmithkline, LLC. | $182.63 | 2019-2022 | |
| Ethicon INC. | $171.39 | 2025 | Monarch Platform |
| Abiomed | $126.45 | 2023 | Impella |
| Genzyme Corporation | $117.47 | 2019-2022 | |
| Mylan Specialty L.P. | $113.76 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $67.17 | 2019-2025 | Breztri |
| Actelion Pharmaceuticals US, INC. | $66.40 | 2021-2024 | Opsumit, Uptravi |
| Philips North America LLC | $58.05 | 2019 | |
| United Therapeutics Corporation | $53.97 | 2019-2024 | Tyvaso |
| Genentech USA, INC. | $52.67 | 2019-2020 | |
| Harmony Biosciences LLC | $45.36 | 2021-2022 | |
| Ambu INC. | $43.61 | 2024-2025 | |
| Shire North American Group INC | $28.31 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $22.54 | 2019 | |
| Jazz Pharmaceuticals INC. | $21.59 | 2021 | |
| Abbvie INC. | $19.95 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $18.18 | 2022 | |
| Pulmonx Corporation | $18.06 | 2022 | |
| Veran Medical Technologies, INC. | $16.63 | 2020 | |
| Vanda Pharmaceuticals INC. | $14.76 | 2021 | |
| Advanced Respiratory, INC | $14.69 | 2020 | |
| Breathe Technologies, INC. | $14.66 | 2019 | |
| Circassia INC. | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.